One Tool to Rule Them All: CRISPR and Emerging Biotechnologies

One Tool to Rule Them All: CRISPR and Emerging Biotechnologies

Some applications of CRISPR are raising ethical and other concerns, and are presenting interesting policy challenges to our current oversight system for research in the life sciences. What can we learn from previous experiences with emerging biotechnologies and how can we adapt our current policy framework to the gene editing technologies of today and tomorrow?